SE434013B - Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav - Google Patents

Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav

Info

Publication number
SE434013B
SE434013B SE7908313A SE7908313A SE434013B SE 434013 B SE434013 B SE 434013B SE 7908313 A SE7908313 A SE 7908313A SE 7908313 A SE7908313 A SE 7908313A SE 434013 B SE434013 B SE 434013B
Authority
SE
Sweden
Prior art keywords
collagen
active substance
weight
depot
binder
Prior art date
Application number
SE7908313A
Other languages
English (en)
Swedish (sv)
Other versions
SE7908313L (sv
Inventor
H Wahlig
E Dingeldein
D Braun
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE7908313L publication Critical patent/SE7908313L/xx
Publication of SE434013B publication Critical patent/SE434013B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE7908313A 1978-10-09 1979-10-08 Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav SE434013B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782843963 DE2843963A1 (de) 1978-10-09 1978-10-09 Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin

Publications (2)

Publication Number Publication Date
SE7908313L SE7908313L (sv) 1980-04-10
SE434013B true SE434013B (sv) 1984-07-02

Family

ID=6051759

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908313A SE434013B (sv) 1978-10-09 1979-10-08 Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav

Country Status (19)

Country Link
US (2) US4291013A (fr)
JP (1) JPS5553214A (fr)
AT (1) AT371724B (fr)
AU (1) AU535839B2 (fr)
BE (1) BE879252A (fr)
CA (1) CA1142433A (fr)
CH (1) CH642845A5 (fr)
CS (1) CS221526B2 (fr)
DD (1) DD146548A5 (fr)
DE (1) DE2843963A1 (fr)
ES (1) ES8101886A1 (fr)
FR (1) FR2438479A1 (fr)
GB (1) GB2032777B (fr)
HU (1) HU180019B (fr)
IL (1) IL58397A (fr)
IT (1) IT1164832B (fr)
NL (1) NL7907450A (fr)
SE (1) SE434013B (fr)
ZA (1) ZA795356B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618560A (en) * 1988-03-24 1997-04-08 Bm Research A/S Controlled release erodible composition

Families Citing this family (252)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
CA1190855A (fr) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Traitement de l'osteite
DE3042860A1 (de) * 1980-11-13 1982-06-09 Heyl & Co Chemisch-Pharmazeutische Fabrik, 1000 Berlin Kollagenpraeparate, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin
GB2091554B (en) * 1981-01-13 1984-09-12 Mitsui Toatsu Chemicals Rod like moulded drug
JPS57128621A (en) * 1981-01-30 1982-08-10 Japan Atom Energy Res Inst Preparation of prolonged release type composite
DK154260C (da) * 1981-02-20 1989-05-22 Mundipharma Gmbh Fremgangsmaade til fremstilling af et knogleimplantat af braendt tricalciumphosphat, specielt til udfyldning af hulrum eller til sammensaetning af knogledele efter fraktur.
US4472840A (en) * 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
FR2520229A1 (fr) * 1982-01-26 1983-07-29 Japan Atomic Energy Res Inst Procede de production d'un compose a degagement lent
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
DE3206726A1 (de) * 1982-02-25 1983-09-01 Merck Patent Gmbh, 6100 Darmstadt Pharmakadepot
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
JPS58170711A (ja) * 1982-03-31 1983-10-07 Japan Atom Energy Res Inst 徐放性複合体の製造方法
FR2524312B1 (fr) * 1982-04-01 1985-10-04 Tech Cuir Centre Nouvelles formes de micro-encapsulation de substances medicamenteuses par des couches homogenes de collagene natif
JPS58225008A (ja) * 1982-06-25 1983-12-27 Japan Atom Energy Res Inst 徐放性複合体の製造方法
EP0115549B1 (fr) * 1983-02-03 1987-11-25 Ethicon, Inc. Pâte pour l'hémostase et pour le soulagement temporaire des défauts dans le traumatisme des os
US4599226A (en) * 1983-03-31 1986-07-08 Genetic Laboratories, Inc. Wound dressing comprising silver sulfadiazine incorporated in animal tissue and method of preparation
DE3317390C2 (de) * 1983-05-13 1985-08-14 Hoechst Ag, 6230 Frankfurt Pharmazeutisches Präparat zur Behandlung von Knocheninfektionen
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
JPH0738880B2 (ja) * 1983-06-24 1995-05-01 東レ株式会社 エンドトキシン血症治療剤
US4525495A (en) * 1983-07-22 1985-06-25 The Dow Chemical Company Mineral filled composites
DE3334595A1 (de) * 1983-09-24 1985-04-18 B. Braun Melsungen Ag, 3508 Melsungen Wirkstoffdepot
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
IL74180A (en) * 1984-01-30 1992-06-21 Meadox Medicals Inc Drug delivery collagen-impregnated synthetic vascular graft
DE3546875C2 (de) * 1984-01-30 1996-05-09 Meadox Medicals Inc Aufschlämmung von Kollagenfibrillen zum blutdichten Beschichten eines flüssigkeitsdurchlässigen synthetischen Gefäßersatz-Substrats
IL74179A (en) * 1984-01-30 1992-05-25 Meadox Medicals Inc Collagen synthetic vascular graft
FR2559780B1 (fr) * 1984-02-21 1990-05-04 Tech Cuir Centre Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
DE3414924A1 (de) * 1984-04-19 1985-10-31 Klaus Dr.med. Dr.med.habil. 8000 München Draenert Beschichtetes verankerungsteil fuer implantate
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
USRE35748E (en) * 1984-05-29 1998-03-17 Matrix Pharmaceutical, Inc. Treatments employing drug containing matrices for introduction into cellular lesion areas
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas
NL8402534A (nl) * 1984-08-17 1986-03-17 Gerrit Johannes Brinks Materiaal, geschikt voor toepassing als implantatiemateriaal bij mens en dier ter vervanging van afwezig botweefsel, alsmede werkwijze ter bereiding van het materiaal.
FR2570606A1 (fr) * 1984-09-26 1986-03-28 Landanger Laboratoire Obturateur notamment de puits femoral ou de fond de cotyle
US5522894A (en) * 1984-12-14 1996-06-04 Draenert; Klaus Bone replacement material made of absorbable beads
US4595713A (en) * 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
US4636526A (en) * 1985-02-19 1987-01-13 The Dow Chemical Company Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics
US4842604A (en) * 1985-02-19 1989-06-27 The Dow Chemical Company Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics
US4661536A (en) * 1985-02-19 1987-04-28 The Dow Chemical Company Process for the preparation of hard tissue prosthetics
US4698375A (en) * 1985-02-19 1987-10-06 The Dow Chemical Company Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics
DE3513938A1 (de) * 1985-04-18 1986-10-23 Merck Patent Gmbh, 6100 Darmstadt Cytostatikahaltiges pharmakadepot
DE3523023A1 (de) * 1985-06-27 1987-01-08 Ruhland Nachf Gmbh Dr Silberhaltige kollagenschwaemme oder kollagenfascien und deren verwendung zur herstellung eines abdeckmaterials fuer hautlaesionen
IL76079A (en) * 1985-08-13 1991-03-10 Univ Ramot Collagen implants
CS253042B1 (en) * 1985-09-25 1987-10-15 Maxmilian Mozisek Haemostatical material
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
DE3542972A1 (de) * 1985-12-05 1987-06-11 Merck Patent Gmbh Pharmakadepot
CH667874A5 (fr) * 1985-12-19 1988-11-15 Battelle Memorial Institute Polypeptide synthetique biodegradable et son utilisation pour la preparation de medicaments.
FR2591892B1 (fr) * 1985-12-23 1988-09-16 Pf Medicament Association collagene/principe actifantiseptique et/ou anti-inflammatoire a titre de composition, son procede de preparation et son utilisation pour la fabrication d'une composition pharmaceutique
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
US4774227A (en) * 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
US5904718A (en) * 1986-03-27 1999-05-18 Biocoll Laboratories, Inc. Delayed drug delivery system
DE3613213A1 (de) * 1986-04-18 1987-10-22 Merck Patent Gmbh Tricalciumphosphat fuer implantationsmaterialien
CA1257199A (fr) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation contenant une substance macromoleculaire ayant des proprietes biologiques liberee pendant plusieurs mois in vivo
IT1197481B (it) * 1986-09-15 1988-11-30 Zambon Spa Preparazione farmaceutica per uso veterinario
US4865602A (en) * 1986-11-06 1989-09-12 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
FR2611496B1 (fr) * 1987-03-04 1992-07-03 Gueyne Jean Organo-silicies cosmetiques
CA1324083C (fr) * 1987-03-09 1993-11-09 Tetsu Miyoshi Preparations pharmaceutiques renfermant des anti-inflammatoires non steroidiens
US5085861A (en) * 1987-03-12 1992-02-04 The Beth Israel Hospital Association Bioerodable implant composition comprising crosslinked biodegradable polyesters
US4843112A (en) * 1987-03-12 1989-06-27 The Beth Israel Hospital Association Bioerodable implant composition
NZ224549A (en) * 1987-05-29 1990-04-26 Ici Australia Operations Controlled release polymer microspheres containing at least one active agent
US5306311A (en) * 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5158574A (en) * 1987-07-20 1992-10-27 Regen Corporation Prosthetic meniscus
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US5263984A (en) * 1987-07-20 1993-11-23 Regen Biologics, Inc. Prosthetic ligaments
US5116374A (en) * 1989-03-02 1992-05-26 Regen Corporation Prosthetic meniscus
US4880429A (en) * 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
WO1989004646A1 (fr) * 1987-11-13 1989-06-01 Jefferies Steven R Materiaux de reparation des os et administration de medicaments retardee
US5139527A (en) * 1987-12-17 1992-08-18 Immuno Aktiengesellschaft Biologic absorbable implant material for filling and closing soft tissue cavities and method of its preparation
EP0326151B1 (fr) * 1988-01-29 1993-06-16 Sumitomo Pharmaceuticals Company, Limited Formulations perfectionnées à libération contrôlée
US5201745A (en) * 1988-03-15 1993-04-13 Imedex Visceral surgery patch
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US5573771A (en) * 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
DE3832162A1 (de) * 1988-09-22 1990-04-12 Lohmann Therapie Syst Lts Verfahren zur herstellung von kollagenschaeumen in form endloser baender und verwendung in medizin, kosmetik und hygiene
US5819748A (en) * 1988-11-30 1998-10-13 Ed Geistlich Sohne Ag Fur Chemische Industrie Implant for use in bone surgery
DE3841397A1 (de) * 1988-12-08 1990-06-21 Melzer Wolfgang Poroeser resorbierbarer arzneistofftraeger
US4975280A (en) * 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
DE3912693A1 (de) * 1989-04-18 1990-10-25 Bioprotan Handels Gmbh Verbundmaterial fuer kosmetische zwecke
JP2805086B2 (ja) * 1989-06-20 1998-09-30 グンゼ株式会社 生体組織用充填材
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
US5061286A (en) * 1989-08-18 1991-10-29 Osteotech, Inc. Osteoprosthetic implant
EP0444197B1 (fr) * 1989-09-15 1994-08-03 Nauchno-Proizvodstvennoe Obiedinenie Komplexnogo Razvitia Meditsinskoi Tekhniki I Izdely Meditsinskogo Naznachenia "Ekran" Endoprothese de l'articulation de la hanche
US5081106A (en) * 1990-07-16 1992-01-14 The Oregon Health Sciences University Wound dressing protocol utilizing collagen gelatin formed with iodine
US5128136A (en) * 1990-07-16 1992-07-07 The Oregon Health Sciences University Wound healing kit comprised of gelable collagen
WO1992013547A1 (fr) * 1991-02-07 1992-08-20 Alexander Mellon Eaton Composition servant a liberer un medicament et procede d'utilisation de la composition
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
AU2572692A (en) 1991-09-09 1993-04-05 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and devices for treating hemophilia and aids
JP3426599B2 (ja) * 1991-11-08 2003-07-14 ヘモゾル インコーポレイテッド 薬物担体としてのヘモグロビン
DE4143239A1 (de) * 1991-12-31 1993-07-01 Joerg Dipl Chem Schierholz Pharmazeutische wirkstoffe enthaltende implantierbare vorrichtung aus einem polymeren material sowie verfahren zu deren herstellung
US5219980A (en) * 1992-04-16 1993-06-15 Sri International Polymers biodegradable or bioerodiable into amino acids
US5641518A (en) * 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5925065A (en) * 1993-06-11 1999-07-20 United States Surgical Corporation Coated gut suture
US5939191A (en) * 1993-06-11 1999-08-17 United States Surgical Corporation Coated gut suture
US5676698A (en) * 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
GB2281709B (en) * 1993-09-14 1998-04-08 Fujitsu Ltd Biodegradable resin moulded article
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6074840A (en) * 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US5928667A (en) * 1994-06-24 1999-07-27 University Of Maryland Drug delivery device and method for employing the same
US5665114A (en) * 1994-08-12 1997-09-09 Meadox Medicals, Inc. Tubular expanded polytetrafluoroethylene implantable prostheses
EP0698396B1 (fr) * 1994-08-12 2001-12-12 Meadox Medicals, Inc. Greffe vasculaire imprégnée d'un matériau d'étanchéité contenant de l'héparine et du collagène
EP0781114B1 (fr) * 1994-09-16 2005-05-25 Ethicon Endo-Surgery, Inc. Dispositifs pour delimiter et marquer des tissus corporels
US6180606B1 (en) 1994-09-28 2001-01-30 Gensci Orthobiologics, Inc. Compositions with enhanced osteogenic potential, methods for making the same and uses thereof
US5707962A (en) * 1994-09-28 1998-01-13 Gensci Regeneration Sciences Inc. Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
US5584857A (en) * 1994-11-14 1996-12-17 United States Surgical Corporation Suture coating and tubing fluid
US5584858A (en) * 1994-11-14 1996-12-17 United States Surgical Corporation Tubing fluid
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
US5788959A (en) * 1995-04-24 1998-08-04 University Of Maryland, Baltimore County Drug delivery device and method for employing the same
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
US6541037B1 (en) 1995-05-19 2003-04-01 Etex Corporation Delivery vehicle
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
GB2311027B (en) * 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
US5668288A (en) * 1996-04-16 1997-09-16 Depuy Orthopaedics, Inc. Polyester ionomers for implant fabrication
US6299905B1 (en) * 1996-04-16 2001-10-09 Depuy Orthopaedics, Inc. Bioerodable polymeric adhesives for tissue repair
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
CZ54899A3 (cs) 1996-08-23 1999-08-11 Cook Biotech, Incorporated Štěpová protéza, materiály s ní spojené a způsoby její výroby
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US5932539A (en) * 1996-10-15 1999-08-03 The Board Of Trustees Of The University Of Illinois Biodegradable polymer matrix for tissue repair
US6972130B1 (en) 1996-10-16 2005-12-06 Etex Corporation Bioceramic compositions
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
DE19713229A1 (de) * 1997-04-01 1998-10-08 Merck Patent Gmbh Antibiotikumhaltige Knochenzementpaste
US6117444A (en) * 1997-04-10 2000-09-12 Brigham & Women's Hospital Polyethylene glycol/microfibrillar collagen composite serves as a resorbable hemostatic agent
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
DE69840361D1 (de) * 1997-07-30 2009-01-29 Univ Emory Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US8668737B2 (en) 1997-10-10 2014-03-11 Senorx, Inc. Tissue marking implant
US6517869B1 (en) 1997-12-12 2003-02-11 Expression Genetics, Inc. Positively charged poly(alpha-(omega-aminoalkyl)lycolic acid) for the delivery of a bioactive agent via tissue and cellular uptake
JP3483753B2 (ja) * 1997-12-29 2004-01-06 タキロン株式会社 生体内分解吸収性可塑性粘着物
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US20030007991A1 (en) * 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US6110484A (en) * 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
CA2319447C (fr) * 1998-12-01 2010-01-26 Washington University Dispositif d'embolisation
CA2355046A1 (fr) 1998-12-14 2000-06-22 Osteotech, Inc. Greffe osseuse et procede de regeneration osseuse guidee
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US7983734B2 (en) 2003-05-23 2011-07-19 Senorx, Inc. Fibrous marker and intracorporeal delivery thereof
US8361082B2 (en) * 1999-02-02 2013-01-29 Senorx, Inc. Marker delivery device with releasable plug
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
US9820824B2 (en) 1999-02-02 2017-11-21 Senorx, Inc. Deployment of polysaccharide markers for treating a site within a patent
US20090216118A1 (en) 2007-07-26 2009-08-27 Senorx, Inc. Polysaccharide markers
US8498693B2 (en) 1999-02-02 2013-07-30 Senorx, Inc. Intracorporeal marker and marker delivery device
DE19912360A1 (de) * 1999-03-19 2000-09-21 Aesculap Ag & Co Kg Strangförmiges Implantat aus resorbierbarem Polymermaterial, Verfahren zu seiner Herstellung und Anwendung in der Chirurgie
US6576246B1 (en) * 1999-05-24 2003-06-10 Seefar Technologies, Inc. Degradable animal chewing article possessing enhanced safety, durability and mouth-feel
US6575991B1 (en) 1999-06-17 2003-06-10 Inrad, Inc. Apparatus for the percutaneous marking of a lesion
WO2001012240A1 (fr) 1999-08-17 2001-02-22 Taki Chemical Co., Ltd. Materiaux biologiques
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
US6387098B1 (en) 1999-10-21 2002-05-14 Peter Alexander Cole Intramedullary catheter nail apparatus and method
US6579533B1 (en) 1999-11-30 2003-06-17 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
US20040009228A1 (en) * 1999-11-30 2004-01-15 Pertti Tormala Bioabsorbable drug delivery system for local treatment and prevention of infections
ATE388726T1 (de) * 2000-03-09 2008-03-15 Syntacoll Ag Neues material auf kollagenbasis mit verbesserten eigenschaften zur verwendung in der human- und veterinärmedizin und ein herstellungsverfahren
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
DE10114364A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Verfahren zur Herstellung von antibiotischen Kompositen
DE10114245A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
US8465516B2 (en) * 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
AU2002326451B2 (en) * 2001-07-26 2008-04-17 Cook Biotech Incorporated Vessel closure member and delivery apparatus
IS6389A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka, sem í eru örholrými, og einnig af þannig húðuðum skrokkum og notkun þeirra
EP1434608B1 (fr) 2001-10-12 2018-08-22 Warsaw Orthopedic, Inc. Greffe osseuse amelioree
CA2483778A1 (fr) * 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Systemes de fixation et de confinement structurels de matrices biologiques et procedes d'utilisation de ceux-ci
DE10227938B4 (de) * 2002-06-21 2006-07-20 Heraeus Kulzer Gmbh Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung
DE10227935B4 (de) * 2002-06-21 2007-10-04 Heraeus Kulzer Gmbh Verfahren zur Herstellung einer antibiotische Beschichtung von porösen Körpern sowie Verwendung
CN102516417B (zh) 2002-09-06 2014-12-10 天蓝制药公司 用于传递治疗剂的以环糊精为基础的聚合物
US20060036158A1 (en) 2003-11-17 2006-02-16 Inrad, Inc. Self-contained, self-piercing, side-expelling marking apparatus
JP4489761B2 (ja) 2003-03-14 2010-06-23 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク マイクロ流体無膜交換装置を有する血液ベースの治療のためのシステム及び方法
US20060076295A1 (en) 2004-03-15 2006-04-13 The Trustees Of Columbia University In The City Of New York Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
JP5189763B2 (ja) * 2003-04-11 2013-04-24 エテックス コーポレーション 骨誘導性骨材料
US7877133B2 (en) 2003-05-23 2011-01-25 Senorx, Inc. Marker or filler forming fluid
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
JP2007503292A (ja) * 2003-06-11 2007-02-22 オステオテック インコーポレーテッド 骨インプラント及びその製造方法
US8465537B2 (en) * 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
GB2408206B (en) * 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
WO2005034852A2 (fr) 2003-08-26 2005-04-21 Gel-Del Technologies, Inc. Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation
US7309232B2 (en) * 2003-10-10 2007-12-18 Dentigenix Inc. Methods for treating dental conditions using tissue scaffolds
CA2548822C (fr) * 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Dispositifs d'administration de medicaments mucoadhesifs et procedes de fabrication et d'utilisation associes
WO2005117919A2 (fr) * 2004-04-15 2005-12-15 Etex Corporation Pates de phosphate de calcium a durcissement retarde
DE102004022645A1 (de) * 2004-05-07 2005-12-15 Resorba Wundversorgung Gmbh & Co. Kg Bioresorbierbares Material auf Kollagen-Basis
US10357328B2 (en) 2005-04-20 2019-07-23 Bard Peripheral Vascular, Inc. and Bard Shannon Limited Marking device with retractable cannula
WO2007056671A1 (fr) 2005-11-02 2007-05-18 Osteotech, Inc. Greffe osseuse hemostatique
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
AU2007253702A1 (en) 2006-05-22 2007-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods of microfluidic membraneless exchange using filtration of extraction fluid outlet streams
BRPI0712088B8 (pt) * 2006-05-31 2021-06-22 Baxter Healthcare Sa uso de uma biomatriz de lâmina de colágeno de múltiplas camadas microscópicas não porosa e hermética a fluido
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US20090171198A1 (en) * 2006-08-04 2009-07-02 Jones Michael L Powdered marker
EP2109409B1 (fr) 2006-12-12 2018-09-05 C.R.Bard, Inc. Marqueur tissulaire pour mode d'imagerie multiple
ES2432572T3 (es) 2006-12-18 2013-12-04 C.R. Bard, Inc. Marcador de biopsia con propiedades de obtención de imágenes generadas in situ
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
CA2703103C (fr) 2007-10-30 2017-05-09 Baxter Healthcare S.A. Utilisation de biomatrice de collagene biofonctionnelle renegeratrice permettant de traiter des lesions parietales ou viscerales
EP2237770A4 (fr) * 2007-12-26 2011-11-09 Gel Del Technologies Inc Particules de protéines biocompatibles, dispositifs à particules et leurs procédés
US20090177203A1 (en) * 2008-01-04 2009-07-09 Inbone Technologies, Inc. Devices, systems and methods for re-alignment of bone
US8496606B2 (en) 2008-02-04 2013-07-30 The Trustees Of Columbia University In The City Of New York Fluid separation devices, systems and methods
EP2259803B2 (fr) 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Dispositif pour la promotion de l homéostasie et/ou la cicatrisation des plaies
US9327061B2 (en) 2008-09-23 2016-05-03 Senorx, Inc. Porous bioabsorbable implant
WO2010048610A2 (fr) 2008-10-24 2010-04-29 Osteotech, Inc. Compositions et procédés pour favoriser la formation osseuse
WO2010057177A2 (fr) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Systèmes de greffe de vaisseaux à biocoacervats et biomatériaux protéiques et procédés pour leur fabrication et leur utilisation
US8670818B2 (en) 2008-12-30 2014-03-11 C. R. Bard, Inc. Marker delivery device for tissue marker placement
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
CN102802683B (zh) * 2009-06-16 2015-11-25 巴克斯特国际公司 止血海绵
EA201200617A1 (ru) * 2009-11-23 2012-11-30 Серулин Фарма Инк. Полимеры на основе циклодекстрина для доставки лекарственных средств
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
US20110237686A1 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc Formulations and methods of use
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
MX345479B (es) 2010-06-01 2017-02-01 Baxter Int Inc * Proceso para elaborar composiciones hemostaticas secas y estables.
BR112012030455B1 (pt) 2010-06-01 2021-08-17 Baxter Healthcare S.A. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, e, kit para administrar uma composição hemostática
JP6289096B2 (ja) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血組成物を作製するためのプロセス
EP2741676A1 (fr) 2011-08-09 2014-06-18 Cook General Biotechnology LLC Flacon utilisable dans des procédures d'extraction de tissu
WO2013053759A2 (fr) 2011-10-11 2013-04-18 Baxter International Inc. Compositions hémostatiques
KR102135484B1 (ko) 2011-10-11 2020-07-20 백스터 인터내셔널 인코포레이티드 지혈 조성물
SA112330957B1 (ar) 2011-10-27 2015-08-09 باكستر انترناشونال انك. تركيبات لإيقاف النزف
CA2865349C (fr) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Recipient mis sous pression contenant de la pate hemostatique
CA2874290C (fr) 2012-06-12 2020-02-25 Ferrosan Medical Devices A/S Composition hemostatique seche
US9364273B2 (en) 2012-08-15 2016-06-14 DePuy Synthes Products, Inc. Drug eluting surgical screw
WO2014055493A1 (fr) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Procédés et systèmes s'appliquant à la précipitation de polymères et à la génération de particules
DE102012023348B4 (de) * 2012-11-29 2016-09-29 Hochschule München Verfahren zur Untersuchung eines Wirkstoffdepots mittels eines bildgebenden Verfahrens
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (fr) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Composition seche comprenant un ameliorateur d'extrusion
US20150216947A1 (en) * 2014-02-03 2015-08-06 George D. Petito Method and composition for tissue/cell repair
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
EP3316930B1 (fr) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Seringue destinée à mélanger deux composants et à maintenir un vide dans une condition de stockage
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법
DE102018218429A1 (de) 2018-10-29 2020-04-30 Heraeus Medical Gmbh Vorrichtung zur temporären, lokalen Applikation von Fluiden
DE102019000322A1 (de) 2019-01-14 2020-07-16 Beuth Hochschule Für Technik Berlin Polymerzusammensetzung mit antiseptischen Eigenschaften und Verfahren zur Herstellung
DE102019000321A1 (de) 2019-01-14 2020-07-16 Beuth Hochschule Für Technik Berlin Orale Polymerzusammensetzung mit verzögerter Freisetzung
EP3854437B1 (fr) 2020-01-27 2022-01-19 Heraeus Medical GmbH Dispositif d'application temporaire et locale des fluides
EP3795196B1 (fr) 2019-09-18 2022-05-11 Heraeus Medical GmbH Dispositif d'application temporaire et locale de fluides
EP3831426A1 (fr) 2019-12-05 2021-06-09 Heraeus Medical GmbH Dispositif d'application locale de fluides pharmaceutiques
DE102020007979A1 (de) 2020-12-29 2022-06-30 Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren
US20220211921A1 (en) * 2021-01-06 2022-07-07 Medtronic Inc. Surgical system and methods of use
EP4094797B1 (fr) 2021-05-28 2023-04-05 Heraeus Medical GmbH Dispositif d'application d'un fluide pharmaceutique
EP4395796A1 (fr) 2021-09-01 2024-07-10 Shanghai Qisheng Biological Preparation Co., Ltd. Régénération de cartilage à l'aide de compositions de collagène injectables polymérisables in situ contenant des chondrocytes ou des cellules souches

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126884A (en) * 1964-03-31 Method of preserving animal tissue
US2967802A (en) * 1957-12-02 1961-01-10 Diamond Lab Hydrated calcium phosphate gelantigen composition and method of preparing same
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
DE1183629B (de) * 1962-12-21 1964-12-17 Behringwerke Ag Verfahren zur Stabilisierung biologisch aktiven Materials
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3435117A (en) * 1966-03-09 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
US3435110A (en) * 1966-03-21 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
US3469003A (en) * 1966-04-01 1969-09-23 Haver Lockhart Lab Inc Injectable reconstituted collagen fluid adjuvant for vaccines and other drugs
GB1195061A (en) * 1966-05-27 1970-06-17 Fmc Corp Coated Structures and Methods of Forming Them.
US3458397A (en) * 1966-12-08 1969-07-29 Squibb & Sons Inc Process for producing osteogenic material
DE1766340A1 (de) * 1967-05-19 1971-07-01 Vyzk Ustav Pletarzsky Textil-Kollagenprothese
US3443261A (en) * 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
FR1604134A (fr) * 1967-09-26 1971-07-12
US3551560A (en) * 1967-10-02 1970-12-29 Heinrich F Thiele Process of reconstructing tendons,cartilage,nerve sheaths,and products
US3563925A (en) * 1967-12-20 1971-02-16 Ceskoslovenska Akademie Ved Composition containing interlocked foams of partly tanned collagen and cross-linked glycol methacrylate polymer
US3639577A (en) * 1968-02-23 1972-02-01 Haver Lockhart Lab Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
US3823212A (en) * 1968-11-27 1974-07-09 Freudenberg C Fa Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers
US3790507A (en) * 1969-03-10 1974-02-05 Research Corp Plastic bone composition
US3887699A (en) * 1969-03-24 1975-06-03 Seymour Yolles Biodegradable polymeric article for dispensing drugs
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3691281A (en) * 1970-02-02 1972-09-12 Fmc Corp Microcrystalline collagen,method of making same and foods,pharmaceuticals and cosmetics containing same
US3821371A (en) * 1970-02-02 1974-06-28 Avicon Inc Pharmaceutical compositions containing microcrystalline collagen,a water-insoluble,ionizable,partial salt of collagen
CA962806A (en) * 1970-06-04 1975-02-18 Ontario Research Foundation Surgical prosthetic device
US3846542A (en) * 1970-07-20 1974-11-05 Kulzer & Co Gmbh Acrylic tooth-filling composition containing boric acid-releasing compound
US3703575A (en) * 1970-12-23 1972-11-21 Heinrich Thiele Reconstructed cartilaginous tissue and method of implanting it into the human or animal body
US3772432A (en) * 1971-01-11 1973-11-13 Lescarden Ltd Cartilage compositions for dental use
US3787900A (en) * 1971-06-09 1974-01-29 Univ Iowa State Res Found Artificial bone or tooth prosthesis material
JPS5221200B2 (fr) * 1971-09-22 1977-06-08
US3758660A (en) * 1971-10-15 1973-09-11 Avicon Inc Method of forming structures from microcrystalline collagen
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US3767437A (en) * 1971-10-20 1973-10-23 Avicon Inc Phosthetic structures derived from collagen
US3808606A (en) * 1972-02-22 1974-05-07 R Tronzo Bone implant with porous exterior surface
FR2181426B1 (fr) * 1972-04-06 1974-12-20 Pasteur Institut
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US3991766A (en) * 1973-05-31 1976-11-16 American Cyanamid Company Controlled release of medicaments using polymers from glycolic acid
US3976071A (en) * 1974-01-07 1976-08-24 Dynatech Corporation Methods of improving control of release rates and products useful in same
US4141864A (en) * 1974-03-15 1979-02-27 University Of Virginia Alumni Patents Foundation Osseous cement composition
IL44697A (en) * 1974-04-23 1977-06-30 Sneer M Dental implants
US3918100A (en) * 1974-05-13 1975-11-11 Us Navy Sputtering of bone on prostheses
FR2278348A2 (fr) * 1974-06-28 1976-02-13 Rhone Poulenc Ind Articles chirurgicaux bioresorbables
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4027676A (en) * 1975-01-07 1977-06-07 Ethicon, Inc. Coated sutures
DE2517452C3 (de) * 1975-04-19 1978-11-02 Fa. Carl Freudenberg, 6940 Weinheim Kollagenfolie für kosmetische Anwendung
JPS5842473B2 (ja) * 1975-09-02 1983-09-20 シャープ株式会社 ハクマク ｅｌ ソシノ クドウホウホウ
AT352867B (de) * 1976-05-12 1979-10-10 Battelle Institut E V Knochenersatz-knochenverbund-oder prothesen- verankerungswerkstoff und verfahren zu seiner herstellung
DE2620907C3 (de) * 1976-05-12 1984-09-20 Battelle-Institut E.V., 6000 Frankfurt Verankerung für hochbelastete Endoprothesen
DE2659916A1 (de) * 1976-05-14 1977-11-24 Pfaudler Werke Ag Verfahren zur herstellung eines implantats mit schleifender oberflaeche
DE2650306A1 (de) * 1976-11-02 1978-05-03 Merck Patent Gmbh Antibakteriell wirkender wundverband und verfahren zu seiner herstellung
AR216922A1 (es) * 1976-11-11 1980-02-15 Merck Patent Gmbh Procedimiento para la fabricacion de un medio quirurgico
DE2724814C3 (de) * 1977-06-02 1980-03-27 Kulzer & Co Gmbh, 6380 Bad Homburg Vorprodukt fur die Zubereitung von Knochenzement
JPS5416671A (en) * 1977-07-08 1979-02-07 Tokyo Shibaura Electric Co Inspection apparatus for print wire board
US4156943A (en) * 1977-08-24 1979-06-05 Collier John P High-strength porous prosthetic device and process for making the same
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
IL56141A (en) * 1977-12-23 1981-10-30 Sterling Drug Inc Whitlockite ceramic and its manufacture
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618560A (en) * 1988-03-24 1997-04-08 Bm Research A/S Controlled release erodible composition

Also Published As

Publication number Publication date
IL58397A0 (en) 1980-01-31
IL58397A (en) 1982-07-30
AU535839B2 (en) 1984-04-05
ATA655079A (de) 1982-12-15
DD146548A5 (de) 1981-02-18
ES484821A0 (es) 1980-12-16
US4347234A (en) 1982-08-31
CH642845A5 (de) 1984-05-15
US4291013A (en) 1981-09-22
GB2032777A (en) 1980-05-14
IT7950493A0 (it) 1979-10-08
BE879252A (fr) 1980-04-08
FR2438479A1 (fr) 1980-05-09
GB2032777B (en) 1983-05-11
NL7907450A (nl) 1980-04-11
AT371724B (de) 1983-07-25
HU180019B (en) 1983-01-28
ZA795356B (en) 1980-09-24
AU5155679A (en) 1980-04-17
FR2438479B1 (fr) 1983-12-30
CS221526B2 (en) 1983-04-29
ES8101886A1 (es) 1980-12-16
DE2843963A1 (de) 1980-04-24
JPS5553214A (en) 1980-04-18
DE2843963C2 (fr) 1988-02-18
SE7908313L (sv) 1980-04-10
IT1164832B (it) 1987-04-15
CA1142433A (fr) 1983-03-08

Similar Documents

Publication Publication Date Title
SE434013B (sv) Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav
US6579533B1 (en) Bioabsorbable drug delivery system for local treatment and prevention of infections
EP0234004A2 (fr) Compositions pharmaceutiques implantables à effet dépôt contenant des inhibiteurs de gyrase
US20060067973A1 (en) Bone void filler
US20040009228A1 (en) Bioabsorbable drug delivery system for local treatment and prevention of infections
ATE262889T1 (de) Verfahren zur herstellung von implantaten, die leuprolid enthalten
IL148704A (en) Sustained release preparations comprising a combination of one or more antibiotics and polymer
JP2000516839A (ja) 皮下注入用、あるいは皮内注入用インプラント
DE3513938A1 (de) Cytostatikahaltiges pharmakadepot
WO2006058777A1 (fr) Procede ameliorant la liberation de medicaments a partir d'un materiau a cet effet
US20220331492A1 (en) Composition and method for controlled drug release from a tissue
BG65505B1 (bg) Метод за получаване на състав, съдържащ антибиотик/антибиотици
KR20060116740A (ko) 흡수성 폴리머 조성물, 임플란트 및 임플란트 제조 방법
BG65499B1 (bg) Метод за получаване на антибиотични смеси
US20110062637A1 (en) Local system for the release of active principle and process for its manufacture
JPH04279520A (ja) 骨内部埋め込み用製剤
KR100289075B1 (ko) 염증치료용서방성임플란트조성물
EP0676408B1 (fr) Procédé de préparation d'agents antibactériens et leur utilisation
JPH07157439A (ja) 骨内部埋め込み用製剤
WO2018082722A1 (fr) Composition polymère thermoplastique biodégradable pour la production d'inserts pour le traitement et la prévention d'infections locales et une méthode pour sa préparation
Benoit et al. Vancomycin-Loaded Calcium Sulfate for the Treatment of Osteomyelitis—Controlled Release by a Poly (Lactide-Co-Glycolide) Polymer
DD205069A1 (de) Verfahren zur herstellung eines therapeutischen mittels

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7908313-5

Effective date: 19891023

Format of ref document f/p: F